III. KONFERENCJA online
CO NOWEGO W ANDROLOGII?
Witamy Państwa bardzo serdecznie
Przedstawimy najnowsze doniesienia z publikacji medycznych, poruszane na międzynarodowych konferencjach m.in.:
- Europejski Kongres Andrologii (European Congress of Andrology, ECA) 16-18 września 2026 w Modenie,
- Coroczny Zjazd Europejskiego Towarzystwa Rozrodu Człowieka i Embriologii (European Society of Human Reproduction and Embriology, ESHRE 42nd Annual Meeting) 5-8 lipca 2026 w Londynie.
- Europejski Kongres Endokrynologii (European Congress of Endocrinology, ECE), który odbył się w dniach 9-12 maja 2026 w Pradze.
Wykłady przeznaczone są dla lekarzy andrologów, także dla przygotowujących się do egzaminu z
andrologii, jak również dla wszystkich pragnących pogłębić czy uaktualnić swoją wiedzę z zakresu
andrologii klinicznej.
Jeśli nie mieliście Państwo okazji brać udziału w powyższych
kongresach, bardzo serdecznie zapraszamy na naszą konferencję online ,,Co nowego w andrologii?”.
PROGRAM KONFERENCJI
Przedstawimy w języku polskim tematy, które pojawią się w doniesieniach z Europejskiego Kongresu Andrologii (European Congress of Andrology, ECA), który odbędzie się w dniach 16-18 września 2026 w Modenie. A będą to m.in.:
- New insights into FSH receptor signalling
- Clinical effects of FSH in male patients with couple infertility
- Deep Phenotyping of Male Infertility Improves the Response to FSH Treatment in Normogonadotropic Oligo-Asthenozoospermia
- Divergent signaling of LH and hCG through the TSH receptor
- Spermatogonial Stem Cell-based therapies: from innovation to implementation
- Practical interpretation of a WES report in diagnosing male infertility
- The Metabolic impact of PDE5 inhibitors: 20 years of trials and Novel findings
- The role of the couple in the Andrology field from sexual dysfunction to infertility
- Impact of male factor on female fertility
- Effects of seminal fluid on female immune receptivity for pregnancy
- Impairment of Male Reproductive Function After Isotretinoin Exposure
- Testicular Biopsies in Adolescent and Adult Andrological Patients
- The remodeling of nuclear transport at the mitosis-to-meiosis transition is a crucial determinant for successful spermatogenesis
- Transgenerational effect of endocrine disruptors at subtoxic dosage on male reproductive function
- Fetal and Adult Leydig cells: A tale of their origin and fate
- Early Life Stress Reprograms Hippo Signaling in the Testis Despite Increased Body Growth: Converging Evidence from Developmental and Mechanistic Models
- High glucose supplementation aggravates experimental autoimmune epididymo-orchitis via localized Th17 skewing in the male reproductive tract
- Beyond weight loss: tirzepatide directly reprograms the testicular transcriptome in male mice with obesity, diabetes and hypogonadism through a caloric restriction-independent mechanism
- Dietary associations with sperm DNA fragmentation in men from infertile couples: Swedish RUBIC data
- Are lifestyle interventions enough in functional hypogonadism?
- Penile Prosthesis – How to deal with difficult cases
- Couple-Based Genetic Screening: Matching Carriers to Uncover Recessive Risks in Male Infertility
- Diffusion-Generated Synthetic Testicular Ultrasound Images for AI Development in Male Infertility Assessment
- In-depth genetic and phenotypic characterisation of CFTR-associated and CFTR-independent congenital bilateral absence of the vas deferens
- Are We Propagating Infertility Through IVF? Genetic Insights into HerITbility
Podejmiemy także hot topics Corocznego Zjazdu Europejskiego Towarzystwa Rozrodu Człowieka i Embriologii (European Society of Human Reproduction and Embriology, ESHRE 42nd Annual Meeting), który odbędzie się w dniach 5-8 lipca 2026 w Londynie.
Wśród najciekawszych:
- High sperm DNA fragmentation is associated with higher chromosome abnormality rates
- Three sources of signals: how extracellular vesicles from the follicular fluid, seminal plasma and mesenchymal stem cells differentially influence male gametes
- Gut-testis axis drives testicular inflammation, aging, and spermatogenesis impairment
- Human sperm function testing – useful or useless
- Clinical and ultrasound andrological parameters predictive for a pregnancy with a live birth
- Slower male pubertal trajectory is associated with elevated serum FSH level, decreased testicular volume, fat-free mass, altered semen quality, sperm epigenetic markers in young adulthood
- Preconditions to parenthood: changes over time and generations
- Associations between healthy and unhealthy dietary patterns and testicular function: a comprehensive analysis of individual food groups
- Exposure to air pollution mixtures during spermatogenesis and sperm DNA methylation in men seeking infertility treatment
- Healthtech in fertility care: personalising treatment for the digital age – meeting the expectations of digitally savvy patients
- Male infertility and risk of cancers
- Genome-wide association study identifies novel loci for semen parameters and testicular volume in idiopathic and unexplained male infertility
- Advanced paternal age associates with lower blastocyst rate and reduced cumulative live birth rate
Przedstawimy również najciekawsze i najbardziej praktyczne zagadnienia poruszane na Europejskim Kongresie Endokrynologii (European Congress of Endocrinology, ECE), który odbył się w dniach 9-12 maja w Pradze. A wśród nich m.in.:
- Male infertility of endocrine origin
- Seeing is believing: imaging live cell behaviour in the pituitary gland
- Efficiacy of Gonadotropin Therapy to Induce Spermatogenesis and Fertility in Men with Pathologic Gonadotropin Deficiency
- Endocrine Modulation of the Hypothalamic–Pituitary–Testicular Axis in Male Infertility: Effects of FSH and Tamoxifen in Selected Patients with Impaired Spermatogenesis
- Non-canonical effects of non-reproductive factors on reproduction
- What an endocrinologist should know about the diagnosis and management of erectile dysfunction?
- The many faces of endocrine disruption
Early life EDC exposure with late effects on health
How to measure EDCs? - Seminal microbiota as an endocrine modulator: Lactobacillus-dependent reprogramming of hormonal networks in male idiopathic infertility
- Dihydrotestosterone versus Testosterone Enanthate: Efficacy among Patients with Micropenis with Congenital Hypogonadotropic Hypogonadism
- Adult testosterone replacement
- Effect of testosterone replacement therapy on fracture risk in men with hypogonadism: a systematic review and meta-analysis of randomized-controlled trials
- Hypogonadism and obesity: practical questions and solutions
- Androgen sensitivity and hypogonadotropic hypogonadism correlate differently and independently with cardiovascular risk in severe obesity
- Role Of The Fgf Signaling Pathway In The Etiopathogenesis Of Congenital Hypogonadotropic Hypogonadism
- A systematic review of gonadotropin and GnRH therapy for the induction or completion of puberty in males with hypogonadotropic hypogonadism
REJESTRACJA
Ceny biletów:
Cena biletu zawiera:
– link do uczestnictwa w konferencji online,
– certyfikat uczestnictwa (przesyłany w wersji cyfrowej)
– możliwość odtwarzania nagrań całości wydarzenia przez 30 dni
W celu wystawienia faktury proforma dla firm sponsorujących uczestnictwo, prosimy o wiadomość mailową z danymi uczestnika i danymi do faktury na adres: [email protected].
KIEROWNIK NAUKOWY KONFERENCJI
Dr n. med.
Katarzyna Jankowska
- specjalista chorób wewnętrznych
- specjalista endokrynologii
- specjalista andrologii klinicznej EAA i PTA
- specjalista immunologii klinicznej
MIEJSCE WYDARZENIA
KONFERENCJA
ONLINE